OrganaBio
Blood & Organ Banks · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7800 SW 57th Ave Ste 308, Miami, Florida...Phone Number
(305) 676-2586Website
www.organabio.comRevenue
<$5 MillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
2
3
2
3
3
About OrganaBio
OrganaBio is dedicated to supporting the development of cell and gene therapies by providing high-quality human biological products and comprehensive clinical services, including cell processing and cryopreservation. Their product offerings include various blood-derived immune cells, hematopoietic stem cells, and mesenchymal stromal cells tailored for innovative therapies. They primarily serve pharmaceutical companies, biopharma firms, clinical trial sponsors, and hospitals, ensuring rapid turnaround times and high success rates in clinical sample processing. With facilities on both U.S. coasts, OrganaBio is positioned to support nationwide clinical trial sites effectively and efficiently.Explore more
OrganaBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OrganaBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when OrganaBio launches new products
Funding: Get notified immidiatlly once OrganaBio has new funding data
OrganaBio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on OrganaBio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at OrganaBio
Check if OrganaBio has recently received funding, and reach out quickly before it becomes old news!
Click to see if OrganaBio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if OrganaBio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to OrganaBio
Compare insights from companies similar to OrganaBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OrganaBio is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
OrganaBio is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about OrganaBio.
OrganaBio financials insights
Gather financial insights about OrganaBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
OrganaBio Tech Stack
A closer look at the technologies used by OrganaBio
See more technologies
Most Recent Scoops
Event
Events
Event
will be attending the Advanced Therapies Week conference as an exhibitor. The event will occur from January 17 to January 20, 2023.
Open Position
Open Position
Facilities Relocation / Expansion
Real Estate
OrganaBio News & Media
OrganaBio Approved as A Science Exchange and Scientist.com Partner
MIAMI--(BUSINESS WIRE)-- #biotech--OrganaBio products and services can now be accessed via the Science Exchange and Scientist.com platforms. Both online marketplaces allow buyers to find and request services directly through the platform and help streamline communication and buying processes through standardized proposal and contracting mechanisms. Drug developers can now leverage www.scienceexchange.com and www.scientist.com and search for OrganaBio’s services and products specifically (e.g. doGaiaGift Triples Physician Network to Ethically Collect Increasing Volumes of Birth Tissues Needed for the Rapidly Burgeoning Development of Cell and Gene Therapies
MIAMI--(BUSINESS WIRE)-- #NeoPAC--GaiaGift, LLC (a wholly owned subsidiary of OrganaBio, LLC) a leader in the field of birth tissue collection, announces the expansion of its esteemed physician network, offering more opportunities for donors to participate in its remarkable donation program supporting the development of novel cell and gene therapies. GaiaGift's mission is to empower families to make a positive impact on healthcare by ethically donating otherwise discarded birth tissue, contributIntroducing NeoPAC™ Tissues: OrganaBio Unveils New Birth Tissue Products to Advance Regenerative Medicine and Cell Therapy
SOUTH MIAMI, Fla.--(BUSINESS WIRE)-- #NeoPAC--OrganaBio is thrilled to announce the launch of NeoPAC™ placenta and umbilical cord tissues, its latest suite of products designed to accelerate the progress of regenerative medicine and cell therapy. By offering both Research Use Only (RUO) and clinical (cGMP) grade tissues, OrganaBio empowers researchers to tap into the potential of birth tissues, enabling the development of innovative therapies to address a wide range of medical conditions. NeoPACOrganaBio Expands Its Operations to the West Coast of the U.S.
SOUTH MIAMI, Fla.--(BUSINESS WIRE)-- #biotech--OrganaBio, LLC, announces the opening of a new laboratory facility in Irvine, California, further expanding its reach and capabilities from the southeast to the west coast. The new facility will offer support services to clinical trial sponsors and CROs, including patient sample processing, analytical testing, cryopreservation, and storage. OrganaBio currently offers a host of cell processing and analytical testing services to support clinical studi
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OrganaBio
Sign Up For FreeTo access detailed company insights
OrganaBio is dedicated to supporting the development of cell and gene therapies by providing high-quality human biological products and comprehensive clinical services, including cell processing and cryopreservation. Their product offerings include various blood-derived immune cells, hematopoietic stem cells, and mesenchymal stromal cells tailored... Read More
